Share Issue News
Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.
Jun 17, 2026 at 12:56 AM
Pattern Announces Pricing of Secondary Offering of Series A Common Stock
LEHI, Utah--(BUSINESS WIRE)--Pattern Group Inc. (Nasdaq: PTRN) (“Pattern”), a leader in accelerating brands on global ecommerce marketplaces leveraging proprietary technology and AI, today announced the pricing of a public offering of 8,000,000 shares of Series A common stock by an entity affiliated with Knox Lane LP, a pre-IPO stockholder of Pattern (the “Selling Stockholder”), at a public offering price of $19.00 per share. The Selling Stockholder granted the underwriters a 30-day option to p...
Jun 16, 2026 at 6:10 PM
Cantor Equity Partners VII, Inc. Announces Pricing of $250 Million Initial Public Offering
NEW YORK--(BUSINESS WIRE)--Cantor Equity Partners VII, Inc. (Nasdaq: CAES) (the “Company”) announced today the pricing of its initial public offering of 25,000,000 Class A ordinary shares at $10.00 per share. The shares are expected to be listed on the Nasdaq Global Market under the symbol “CAES” and begin trading on June 17, 2026. The underwriters have been granted a 45-day option to purchase up to an additional 3,750,000 shares offered by the Company to cover over-allotments, if any. The offe...
Jun 16, 2026 at 4:05 PM
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Jun 16, 2026 at 4:01 PM
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on June 15, 2026, it granted stock options to purchase an aggregate of 103,020 shares of common stock to nine n...
Jun 16, 2026 at 4:01 PM
CEL-SCI Announces Closing of Offering
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI announces closing of offering....
Jun 16, 2026 at 8:00 AM
Abrams Capital Disposes of Shares of SECURE Waste Infrastructure Corp.
BOSTON--(BUSINESS WIRE)--Abrams Capital Management, L.P. (“Abrams Capital”), a holder of common shares (“Common Shares”) of SECURE Waste Infrastructure Corp. (TSX: SES) (“SECURE”), announces that on June 15, 2026, funds managed by it disposed of an aggregate of 11,400 Common Shares on the open market through the facilities of the Toronto Stock Exchange. Prior to the dispositions of Common Shares, Abrams Capital had ownership and control over Common Shares, representing approximately 10% of the...
Jun 16, 2026 at 6:49 AM
Sable Offshore Corp. Announces Commencement of New Senior Secured Term Loan
HOUSTON--(BUSINESS WIRE)--Sable Offshore Corp. Announces Commencement of New Senior Secured Term Loan...
Jun 15, 2026 at 4:05 PM
Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08
SAN FRANCISCO--(BUSINESS WIRE)--Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that on June 12, 2026, its Compensation Committee granted an equity award pursuant to the Chegg 2023 Equity Inducement Plan. One newly hired employee received an award of restricted stock units (“RSUs”) representing 400,000 shares of Chegg common stock in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08. The award of Restricted Stock Units shal...
Jun 15, 2026 at 4:01 PM
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to six newly hired non-executive employees consisting of options to purchase an aggregate of 155,480 common shares of the Company (the "Options") with effective grant dates of June 15, 2026....
Jun 12, 2026 at 4:30 PM
Skillsoft Announces New Employee Inducement Grant Under NYSE Rule 303A.08
BOSTON--(BUSINESS WIRE)--Skillsoft Corp. (NYSE: SKIL) (“Skillsoft” or the “Company”), a leading AI-native skills management platform, today announced that on June 12, 2026, the Talent and Compensation Committee (the “Committee”) of Skillsoft’s Board of Directors (the “Board”) made a grant of 150,000 restricted stock units (“RSUs”) with respect to the Company’s Class A common stock to Ronald Kisling. The grant of RSUs was offered as a material inducement to Mr. Kisling’s hiring as Chief Financia...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.